Oral anticoagulation therapy

DRUG2 trials

Sponsors

Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland, China National Center for Cardiovascular Diseases

Conditions

Antithrombotic TherapyAtrial FibrillationBioprosthetic Valve ThrombosisSafety IssuesStroke PreventionTranscatheter Aortic Valve Replacement

Phase 4

Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR

China National Center for Cardiovascular DiseasesAntithrombotic Therapy, Bioprosthetic Valve Thrombosis, Transcatheter Aortic Valve Replacement

Start: 2023-07-27End: 2025-12-31Target: 650Updated: 2023-10-23

Unknown Phase

Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.

Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, PolandAtrial Fibrillation, Safety Issues, Stroke Prevention

Start: 2015-06-08End: 2025-01-01Target: 100Updated: 2019-03-05

Related Papers

Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial

BMJ Open2023-11-011 citations